Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple inflammatory signaling pathways and cytokine networks refers to the complex, interconnected web of intracellular cascades and extracellular proteins that regulate the body's immune and inflammatory responses. This system includes major signaling axes such as the NF-κB, JAK-STAT, MAPK, and NLRP3 inflammasome pathways, which are activated by pattern recognition receptors (PRRs) or cytokine receptors [1][2]. These pathways drive the expression and secretion of various cytokines, including TNF-α, IL-1, IL-6, and IL-17, which further amplify the inflammatory signal through autocrine and paracrine loops [3]. Dysregulation of these networks is a primary driver of chronic inflammatory diseases like rheumatoid arthritis and Crohn's disease, as well as acute conditions like cytokine release syndrome (CRS) [4]. While the term itself is too broad to represent a single drug target, it encompasses numerous validated targets for which biologicals and small molecules have been developed, such as TNF inhibitors and JAK inhibitors [5]. Therapeutic strategies often aim to selectively inhibit specific nodes within these networks to suppress pathological inflammation while maintaining sufficient immune surveillance. Consequently, this entry describes a physiological system rather than a discrete molecular target suitable for specific pharmacological profiling. Citations: [1] Liu, T., et al. (2017). NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy. [2] Hu, X., et al. (2021). The JAK-STAT pathway in health and disease. Nature Reviews Rheumatology. [3] Dinarello, C. A. (2011). Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. [4] Feldmann, M., & Maini, R. N. (2003). TNF defined as a therapeutic target for rheumatoid arthritis and beyond. Nature Medicine. [5] O'Shea, J. J., et al. (2013). The JAK-STAT pathway: biology, therapeutics and beyond. Nature Reviews Drug Discovery.
Modulation of immune signaling through cytokine neutralization, receptor antagonism, or intracellular kinase inhibition.
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple inflammatory signaling pathways and cytokine networks.